FLESHER GREGORY J. 4
4 · Reneo Pharmaceuticals, Inc. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
FLESHER GREGORY J.
DirectorPresident and CEO
Transactions
- Award
Stock option (right to buy)
2022-12-09+300,000→ 300,000 totalExercise: $1.80Exp: 2032-12-08→ Common Stock (300,000 underlying)
Holdings
- 115,200
Common Stock
Footnotes (2)
- [F1]Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on June 8, 2022 and 4,000 shares acquired under the Plan on December 8, 2022.
- [F2]The shares vest in a series of 16 equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.